Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

DES Home | For Consumers | For Health Care Providers
For DES Update Partners | Contact Us
DES Update: Health Care Providers
DES Update: Health Care Providers


 Health Care Providers Home
 Information to Identify and Manage DES Patients
 Patients Prescribed DES While Pregnant
 DES Daughters
 DES Sons
 Offspring of DES Daughters and Sons
 Supplemental DES Materials for Nurses
 Pharmacology
 DES Brand Names
 Resources and Educational Tools
 DES References

Email this page
Order DES materials
Image of a young man  Information to Identify and Manage DES Patients
Health Care Providers Home > Information to Identify and Manage DES Patients > Patients Who Are DES Sons > Health Risks and Related Concerns for DES Sons
Patients Who Are DES Sons

Patients Who Are DES Sons

 Overview
 Identification of DES Sons
 Health Risks and Related Concerns for DES Sons
 Counseling DES Sons
 DES References: Research on DES Sons
Health Risks and Related Concerns for DES Sons

Genitourinary Abnormalities

Few studies have been conducted on health risks for men exposed to DES in utero (DES Sons). These have generally yielded mixed results. An increased risk of epididymal cysts has been documented in DES Sons in several studies (196,201,209,225,236). These demonstrated that 21% of DES Sons had epididymal cysts, compared to 5% of unexposed men. Risks of other genital abnormalities, including testicular hypoplasia, cryptorchidism, and microphallus have been reported to be more common among DES Sons in some studies, but not others (206,236).

Lack of Increased Risk of Infertility

Data from a prospective, blinded, placebo-controlled study of prenatal DES exposure confirmed no impairment in fertility in men exposed to DES in utero (DES Sons) (2,236).

Related Concerns

The principle issues limiting firm conclusions about effects of DES on men exposed in utero (DES Sons) have been small sample size, lack of randomization, and the relative youth of the study cohort. From a clinical standpoint, the most important issue is that the median age of men in reported DES cohort studies is less than 50. Thus it is possible that health effects may be found that affect elderly DES Sons that are not currently recognized.

Significant bias is introduced into non-randomized studies because men with genital abnormalities are more likely to investigate whether they were exposed to DES, and thus be identified as DES Sons. Data from a cohort of offspring of women randomized to DES or placebo during pregnancy exist, but sample sizes are relatively small.

Genital Abnormalities

Increased risk of epididymal cysts has been documented consistently in DES Sons. Risks of other genital abnormalities (testicular hypoplasia, cryptorchidism, microphallus) have been associated with DES exposure in some studies, but not others (206,217,233,236). It is unlikely that this issue will ever be definitively resolved.

Testicular Cancer

Some case control studies have suggested an increased risk of testicular cancer in DES Sons, others have not. A prospective randomized study found a trend to increased levels of testicular cancer compared to a control group that was not statistically significant (231). Based on animal studies, it is possible that significant cancer risks will be identified as men age.

Rete Testis and Prostatic Utricular Cancer

Studies of mice exposed prenatally to DES have demonstrated an increased incidence of tumors of the rete testes and metaplastic, dysplastic, and neoplastic changes in the Prostatic utricle (219,220,221,223,224,225). These organs develop from the same embryonic tissue (the Müllerian duct) as the vagina, the site of known increased cancer risk in DES Daughters. Cancers develop in older DES-exposed mice, correlating to old age in humans. Although such tumors have not been demonstrated to occur more frequently in DES Sons, the possibility remains that they will be detected as the cohort ages.

For a complete list of the numbered citations on this page see DES References.

Back to Top

Contact Us | Site Map | Privacy Policy | Disclaimer | FOIA | Accessibility

CDC Home | Search | Health Topics A-Z



United States Department of Health and Human Services
Centers for Disease Control and Prevention